BNTX Investors Have Opportunity to Lead BioNTech SE Securities Fraud Lawsuit

LOS ANGELES, Feb. 28, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX). Class Period: March 30, 2022…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks